The SA Journal Diabetes & Vascular Disease Vol 16 No 1 (July 2019)

19 / 48

SA JOURNAL OF DIABETES & VASCULAR DISEASE RESEARCH ARTICLE
VOLUME 16 NUMBER 1 • JULY 2019 17
14. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular
filtration rate. Ann Intern Med 2009; 150(9): 604–612. doi: 10.7326/0003-4819-
150-9-200905050-00006.
15. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the
management of arterial hypertension: the task force for the management of
arterial hypertension of the European Society of Hypertension (ESH) and of the
European Society of Cardiology (ESC). Eur Heart J 2013; 34(28): 2159–2219. doi:
10.1093/eurheartj/eht151.
16. World Health Organization. Definition and diagnosis of diabetes mellitus and
intermediate hyperglycemia:Report of a WHO/IDF consultation. Production 2006:
1–52. doi: ISBN 92 4 159493 4.
17. National Cholesterol Education Program (NCEP) expert Panel. Third report
of the National Cholesterol Education Program (NCEP) Expert Panel on
Detection, Evaluation and Treatment of High Blood Cholesterol in Adults
(Adult Treatment Panel III). Arch Intern Med 2002; 6: 284. doi: 10.1001/
archinte.1991.00400060019005.
18. Of OJOS, Kidney Disease: Improving Global Outcomes (KDIGO) CKD work group.
KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management
of Chronic Kidney Disease. Kidney Int Suppl 2013; 3(1): 5–14. doi: 10.1038/
kisup.2012.76.
19. Dhungana R, Devkota S, Khanal MK, et al. Prevalence of cardiovascular health
risk behaviors in a remote rural community of Sindhuli district, Nepal. BMC
Cardiovasc Disord 2014; 14(1): 92. doi: 10.1186/1471-2261-14-92.
20. Zaman MM, Rahman MM, Rahman MR, Bhuiyan MR, Karim MN, Chowdhury
MAJ. Prevalence of risk factors for non-communicable diseases in Bangladesh:
Results from STEPS survey 2010. Indian J Public Health 2016; 60(1): 17–25. doi:
10.4103/0019-557X.177290.
21. Okpechi IG, Chukwuonye II, Tiffin N, et al. Blood pressure gradients and
cardiovascular risk factors in urban and rural populations in Abia State south
eastern Nigeria using the WHO STEPwise approach. PLoS One 2013; 8(9): 4–6.
doi: 10.1371/journal.pone.0073403.
22. Lachat C, Otchere S, Roberfroid D,et al. Diet and physical activity for the prevention
of noncommunicable diseases in low- and middleincome countries: a systematic
policy review. PLoS Med 2013; 10(6). doi: 10.1371/journal.pmed.1001465.
23. Iwuala SO, Sekoni AO, Olamoyegun MA, Akanbi MA, Sabir AA, Ayankogbe OO.
Self-reported physical activity among health care professionals in south and west
Nigeria. Niger J Clin Pract 2015; 18(6): 790–795.
24. Baragou S, Djibril M, Atta B, Damorou F, Pio M, Balogou A. Prevalence of
cardiovascular risk factors in an urban area of Togo: a WHO STEPS-wise approach
in Lome, Togo. Cardiovasc J Afr 2012; 23(6): 309–312. doi: 10.5830/CVJA-2011-
071.
25. Zaman MM, Bhuiyan MR, Karim MN, et al . Clustering of noncommunicable
diseases risk factors in Bangladeshi adults: An analysis of STEPS survey 2013.
BMC Public Health 2015; 15: 659. doi: 10.1186/s12889-015-1938-4.
26. Aryeetey R, Ansong J. Overweight and hypertension among college of health
sciences employees in Ghana. Afr J Food Agric Nutr Devt 2011; 11(6): 5444–
5456. doi: 10.4314/ajfand.v11i6.
27. Fawibe AE, Shittu AO. Prevalence and characteristics of cigarette smokers among
undergraduates of the University of Ilorin, Nigeria. Niger J Clin Pract 2011; 14(2):
201–205. doi: 10.4103/1119-3077.84016.
28. Aryal KK, Mehata S, Neupane S, et al. The burden and determinants of non
communicable diseases risk factors in Nepal: Findings from a nationwide STEPS
survey. PLoS One 2015; 10(8): 1–18. doi: 10.1371/journal.pone.0134834.
29. Zaborskis A, Sirvyte D. Familial determinants of current smoking among
adolescents of Lithuania: a cross-sectional survey 2014. BMC Public Health 2015;
15(1): 889. doi: 10.1186/s12889-015-2230-3.
30. Crichton GE, Alkerwi A. Physical activity, sedentary behavior time and lipid levels
in the Observation of Cardiovascular Risk Factors in Luxembourg study. Lipids
Health Dis 2015; 14(1): 87. doi: 10.1186/s12944-015-0085-3.
31. Daviglus ML, Talavera GA, Avilés-santa ML, Giachello AL, Gouskova N, Kaplan RC.
NIH Public Access 2013; 308(17): 1775–1784. doi: 10.1001/jama.2012.14517.
Prevalence.
32. Phaswana-Mafuya N, Peltzer K, Chirinda W, Musekiwa A, Kose Z. Socio-
demographic predictors of multiple non-communicable disease risk factors
among older adults in South Africa. Glob Health Action 2013; 6(1): 1–8. doi:
10.3402/gha.v6i0.20680.
33. Truthmann J, Busch MA, Scheidt-Nave C, et al. Modifiable cardiovascular risk
factors in adults aged 40–79 years in Germany with and without prior coronary
heart disease or stroke. BMC Public Health 2015; 15(1): 701. doi: 10.1186/
s12889-015-1929-5.
34. Wu F, Guo Y, Chatterji S, et al. Common risk factors for chronic noncommunicable
diseases among older adults in China, Ghana, Mexico, India, Russia and South
Africa: the study on global AGEing and adult health (SAGE) wave 1. BMC Public
Health 2015; 15(1): 88. doi: 10.1186/s12889-015-1407-0.
35. Seck SM, Guéye S, Tamba K, Ba I. Prevalence of chronic cardiovascular and
metabolic diseases in Senegalese workers: a cross-sectional study, 2010. Prev
Chronic Dis 2013; 10(5): 110339. doi: 10.5888/pcd10.110339.
36. Villegas R, Kearney PM, Perry IJ. The cumulative effect of core lifestyle behaviours
on the prevalence of hypertension and dyslipidemia. BMC Public Health 2008;
8(1): 210. doi: 10.1186/1471-2458-8-210.
37. Oluyombo R, Olamoyegun MA, Olaifa O, Iwuala SO, Babatunde OA.
Cardiovascular risk factors in semi-urban communities in southwest Nigeria:
Patterns and prevalence. J Epidemiol Glob Health 2015; 5(2): 167–174. doi:
10.1016/j.jegh.2014.07.002.
38. Msyamboza KP, Ngwira B, Dzowela T, et al. The burden of selected chronic non-
communicable diseases and their risk factors in malawi: Nationwide steps survey.
PLoS One 2011; 6(5): 6–11. doi: 10.1371/journal.pone.0020316.
39. Ogna VF, Ogna A, Ponte B, et al . Prevalence and determinants of chronic kidney
disease in the Swiss population. Swiss Med Wkly 2016; 146: 14313. doi: 10.4414/
smw.2016.14313.
40. Hallan SI, Coresh J, Astor BC, et al. International Comparison of the relationship
of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006;
17(8): 2275–2284. doi: 10.1681/ASN.2005121273.
41. Ji E, Kim YS. Prevalence of chronic kidney disease defined by using CKD-EPI
equation and albumin-to-creatinine ratio in the Korean adult population. Korean
J Intern Med 2016; 31(6): 1120–1130.
42. Seck SM, Doupa D, Guéye L, Dia CA. Epidemiology of chronic kidney disease in
northern region of Senegal: A community-based study in 2012. Pan Afr Med J
2014; 18: 1–8. doi: 10.11604/pamj.2014.18.307.3636.
43. Kaze FF, Halle M-P, Mopa HT, et al . Prevalence and risk factors of chronic kidney
disease in urban adult Cameroonians according to three common estimators of
the glomerular filtration rate: a cross-sectional study. BMC Nephrol 2015; 16(1):
96. doi: 10.1186/s12882-015-0102-9.
44. Egbi OG, Okafor UH, Miebodei KE, Kasia BE, Kunle-Olowu OE, Unuigbe EI.
Prevalence and correlates of chronic kidney disease among civil servants in Bayelsa
state, Nigeria. Niger J Clin Pract 2014; 17(5): 602–607. doi: 10.4103/1119-
3077.141426.
45. Ulasi II, Ijoma CK, Onodugo OD, Arodiwe EB, Ifebunandu NA, Okoye JU.
Towards prevention of chronic kidney disease in Nigeria: a community-based
study in Southeast Nigeria. Kidney Int Suppl 2013; 3(2): 195–201. doi: 10.1038/
kisup.2013.13.
46. Odenigbo C, Oguejiofor O, Onwubuya E, Onwukwe C. The prevalence of chronic
kidney disease in apparently healthy retired subjects in asaba, Nigeria. Ann Med
Health Sci Res 2014; 4(Suppl 2): S128–S132. doi: 10.4103/2141-9248.138031.
47. Oladapo OO, Salako L, Sodiq O, Shoyinka K, Adedapo K, Falase AO. A prevalence
of cardiometabolic risk factors among a rural Yoruba south-western Nigerian
population: a population-based survey. Cardiovasc J Afr 2010; 21(1): 26–31.
.
nih.gov/articlerender fcgi?artid=PMC3721297.
48. Stamler J, Elliott P, Appel L, et al. Higher blood pressure in middle-aged American
adults with less education-role of multiple dietary factors: the INTERMAP study. J
Hum Hypertens 2003; 17(9): 655–775. doi: 10.1038/sj.jhh.1001608.
49. Craig SR, Amin RV, Russell DW, Paradise NF. Blood cholesterol screening: Influence
of fasting state on cholesterol results and management decisions. J Gen Intern
Med 2000; 15(6): 395–399. doi: 10.1046/j.1525-1497.2000.03509.x.
50. Mora S, Rifai N, Buring JE, Ridker PM. Fasting compared with non-fasting lipids
and apolipoproteins for predicting incident cardiovascular events. Circulation
2008; 118(10): 993–1001. doi: 10.1161/CIRCULATIONAHA.108.777334.